Publications: Our research

Filter
Research Area
Technology
Resource type
Category
168 results found
May 6, 2025
Pre-print
Novavax led
bioRxiv
Matrix-M™ adjuvant
Matrix-M® adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization.
Zarnegar B, Carow B, Eriksson J, et al.
Apr 12, 2025
Pre-print
Novavax led
medRxiv
COVID-19
Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents.
Gwak E, Choe S-Ah, Kim K et al.
Apr 10, 2025
Publication
Novavax led
medRxiv
COVID-19
Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up.
Alves K, Kotloff K, McClelland S et al.
Apr 2, 2025
Publication
Novavax led
Vaccine
COVID-19
Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: primary day-28 analysis of a phase 2/3 open-label study.
Alves K, Kouassi A, Plested JS et al.
Mar 28, 2025
Pre-print
Novavax led
medRxiv
COVID-19
Anti-Spike IgG4 and Fc Effector Responses: The Impact of SARS-CoV-2 Vaccine Platform–Specific Priming and Immune Imprinting
Kalkeri R, Zhu M, Cloney-Clark S et al.
Mar 26, 2025
Publication
Novavax led
Journal of Allergy and Clinical Immunology
COVID-19
Immunogenicity of Adjuvanted Recombinant SARS-CoV-2 Spike Protein Vaccine after Earlier mRNA Vaccine Doses
Adelglass JM, Bradley P, Cai MR et al.
Feb 14, 2025
Publication
Novavax led
Vaccines
COVID-19
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model.
Clive Pritchard, Lucie Kutikova, Richard Pitman, et al.
Jan 31, 2025
Publication
Novavax led
Vaccine
COVID-19
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review
Manuela H. Gschwend, Anthony M. Marchese, Dirk Poelaert, et al.
Jan 30, 2025
Publication
Novavax led
ScienceDirect
Safety and immunogenicity of Omicron protein vaccines in mRNA-vaccinated adolescents: A phase 3, randomised trial
Chijioke Bennett, Gordon Chau, Erika Clayton et al.
Jan 22, 2025
Pre-print
Novavax led
medRxiv
COVID-19
Detection of anti–SARS-CoV-2 mucosal IgA in clinical saliva samples after a dose of Novavax COVID-19 vaccine
Mingzhu Zhu, Edmond Massuda, Urvashi Patel, et al.